CIK 0001446159 · Non-accelerated filer<br>Smaller reporting company
AXE COMPUTE INC.
Sign in to watch- Ticker
- AGPU
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 331007393
- Phone
- 305-563-3850
- Business address
- 801 BRICKELL AVENUE, SUITE 510, MIAMI, FL, 33131
- Former names
- Predictive Oncology Inc., Precision Therapeutics Inc., Skyline Medical Inc., BioDrain Medical, Inc.
- Open-market buys, last 90 days
- $98,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$98,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −121 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +121 | 121 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −133 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +133 | 133 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −59 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +59 | 59 | ||
| 2020-09-01 | GABRIEL RICHARD L Director | Purchase | +4,000 | $0.90 | $4K | 12,070 |
| 2020-08-19 | GABRIEL RICHARD L Director | Purchase | +390 | $1.18 | $460 | 5,460 |
| 2020-08-19 | GABRIEL RICHARD L Director | Purchase | +2,610 | $1.18 | $3K | 8,070 |
| 2020-07-10 | ST. CLAIR GREGORY SR Director | Grant or award | +4,698 | 4,698 | ||
| 2020-07-10 | Nuzum Charles Lee Sr Director | Grant or award | +6,712 | 6,712 | ||
| 2020-07-10 | CHUNG-WELCH NANCY Director | Grant or award | +4,698 | 4,698 | ||
| 2020-06-30 | Reding Andrew P. Director | Grant or award · Stock Options (right to buy) | +3,049 | 3,049 | ||
| 2020-06-30 | GABRIEL RICHARD L Director | Grant or award · Stock Options (right to buy) | +3,049 | 3,049 | ||
| 2020-06-30 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +3,049 | 3,049 | ||
| 2020-06-30 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +3,049 | 3,049 | ||
| 2020-06-30 | HANDLEY DANIEL E Director | Grant or award · Stock Options (right to buy) | +3,049 | 3,049 | ||
| 2020-06-17 | Reding Andrew P. Director | Grant or award | +4,070 | 4,076 | ||
| 2020-06-17 | ENGLE J MELVILLE Director | Grant or award | +4,070 | 4,070 | ||
| 2020-06-17 | GABRIEL RICHARD L Director | Grant or award | +4,070 | 5,070 |
Page 11 of 20 · 384 trades